Aligos Therapeutics Inc expected to post a loss of 16 cents a share - Earnings Preview

Aligos Therapeutics

03/08/2024 01:01

* Aligos Therapeutics Inc  ALGS.OQ   ALGS.O  is expected
to show a
fall in quarterly revenue when it reports  results on August 6
for the period ending June 30 2024
    * 
    * ​LSEG's mean analyst estimate for Aligos Therapeutics Inc
is for
a loss of 16 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Aligos
Therapeutics Inc is $7.00​, above​ its last closing price
of $0.49. ​​​

This summary was machine generated August 3 at 00:01 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)